|
SLFN12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.311600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.277800E-01 |
| Normal-vs-Stage2 |
6.395800E-01 |
| Normal-vs-Stage3 |
5.600200E-01 |
| Normal-vs-Stage4 |
7.226600E-01 |
| Stage1-vs-Stage2 |
7.578200E-01 |
| Stage1-vs-Stage3 |
5.936600E-01 |
| Stage1-vs-Stage4 |
1.888390E-01 |
| Stage2-vs-Stage3 |
9.572200E-01 |
| Stage2-vs-Stage4 |
4.775600E-01 |
| Stage3-vs-Stage4 |
3.600600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.440000E-01 |
| Normal-vs-AfricanAmerican |
2.693700E-02 |
| Normal-vs-Asian |
7.407600E-01 |
| Caucasian-vs-AfricanAmerican |
1.250980E-01 |
| Caucasian-vs-Asian |
5.971800E-01 |
| AfricanAmerican-vs-Asian |
1.048980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.009200E-01 |
| Normal-vs-Female |
2.670800E-01 |
| Male-vs-Female |
4.700800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.665610E-01 |
| Normal-vs-Age(41-60Yrs) |
3.505800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.705400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.642000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.952400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.688590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.031200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.714400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.374600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.691800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.201980E-01 |
| Classical-VS-Follicular |
6.303800E-03 |
| Classical-VS-Other |
1.536620E-01 |
| Classical-VS-Normal |
4.465700E-02 |
| Tall-VS-Follicular |
6.134400E-01 |
| Tall-VS-Other |
5.050200E-01 |
| Tall-VS-Normal |
8.557200E-01 |
| Follicular-VS-Other |
7.721400E-01 |
| Follicular-VS-Normal |
4.323400E-01 |
| Other-VS-Normal |
4.027200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.019400E-01 |
| Normal-vs-N1 |
5.175800E-01 |
| N0-vs-N1 |
9.736000E-01 |
|
|
